Related content

Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs

By Sheffield Leslie J   Irving Peter   Gupta Arun   Byron Keith   Macrae Finlay A   Phillimore Hazel   Dronavalli Mithilesh   Rose Rosemary   George Peter   Walmsley Trevor   Dixon Barbara   Poole Susan   Dooley Michael   Sparrow Miles  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1091-1099

Future Medicine

Access to resources Recommend Favorite

Allopurinol–thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle?

By Roberts Rebecca L   Gearry Richard B   Barclay Murray L  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1505-1508

Future Medicine

Access to resources Recommend Favorite

Thiopurine Treatment in Inflammatory Bowel Disease

By Gardiner Sharon J.  

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 803-804

Adis International

Access to resources Recommend Favorite

A Rapid and Robust HPLC- DAD Method for the Monitoring of Thiopurine Metabolites in Whole Blood: Application to Paediatric Patients with Inflammatory Bowel Disease

By  

Current Pharmaceutical Analysis, Vol. 11, Iss. 2, 2015-05 ,pp. : 80-85

Bentham Science Publishers

Access to resources Recommend Favorite

Pretravel preparation and travel-related morbidity in patients with inflammatory bowel disease

By Soonawala Darius   van Eggermond Anna M.   Fidder Herma   Visser Leo G.  

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2079-2085

Blackwell Publishing

Access to resources Recommend Favorite